438 related articles for article (PubMed ID: 18263586)
1. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG
J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586
[TBL] [Abstract][Full Text] [Related]
2. Linear relationship between ADAMTS13 activity and platelet dynamics even before severe thrombocytopenia.
Song J; Lee KA; Park TS; Park R; Choi JR
Ann Clin Lab Sci; 2008; 38(4):368-75. PubMed ID: 18988930
[TBL] [Abstract][Full Text] [Related]
3. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.
Bao J; Xiao J; Mao Y; Zheng XL
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063
[TBL] [Abstract][Full Text] [Related]
4. FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients.
Mancini I; Valsecchi C; Lotta LA; Deforche L; Pontiggia S; Bajetta M; Palla R; Vanhoorelbeke K; Peyvandi F
Thromb Haemost; 2014 Aug; 112(2):297-303. PubMed ID: 24740645
[TBL] [Abstract][Full Text] [Related]
5. Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B.
Rayes J; Hollestelle MJ; Legendre P; Marx I; de Groot PG; Christophe OD; Lenting PJ; Denis CV
Blood; 2010 Jun; 115(23):4870-7. PubMed ID: 20200350
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin.
Chen J; Ling M; Fu X; López JA; Chung DW
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2625-30. PubMed ID: 22922961
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.
Crawley JT; de Groot R; Xiang Y; Luken BM; Lane DA
Blood; 2011 Sep; 118(12):3212-21. PubMed ID: 21715306
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site.
Raife TJ; Cao W; Atkinson BS; Bedell B; Montgomery RR; Lentz SR; Johnson GF; Zheng XL
Blood; 2009 Aug; 114(8):1666-74. PubMed ID: 19541819
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation.
Serrano SMT; Wang D; Shannon JD; Pinto AFM; Polanowska-Grabowska RK; Fox JW
FEBS J; 2007 Jul; 274(14):3611-3621. PubMed ID: 17578514
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein B100/Low-Density Lipoprotein Regulates Proteolysis and Functions of von Willebrand Factor under Arterial Shear.
Cao W; Abdelgawwad MS; Li J; Zheng XL
Thromb Haemost; 2019 Dec; 119(12):1933-1946. PubMed ID: 31493779
[TBL] [Abstract][Full Text] [Related]
11. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
12. Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions.
Dong JF; Cruz MA; Aboulfatova K; Martin C; Choi H; Bergeron AL; Martini SR; Kroll MH; Kent TA
Thromb Haemost; 2008 Mar; 99(3):586-93. PubMed ID: 18327408
[TBL] [Abstract][Full Text] [Related]
13. Zinc and calcium ions cooperatively modulate ADAMTS13 activity.
Anderson PJ; Kokame K; Sadler JE
J Biol Chem; 2006 Jan; 281(2):850-7. PubMed ID: 16286459
[TBL] [Abstract][Full Text] [Related]
14. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of snake venom toxins interacting with human von Willebrand factor.
Matsui T; Hamako J
Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
[TBL] [Abstract][Full Text] [Related]
16. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.
Furlan M; Robles R; Lämmle B
Blood; 1996 May; 87(10):4223-34. PubMed ID: 8639781
[TBL] [Abstract][Full Text] [Related]
17. Probing ADAMTS13 substrate specificity using phage display.
Desch KC; Kretz C; Yee A; Gildersleeve R; Metzger K; Agrawal N; Cheng J; Ginsburg D
PLoS One; 2015; 10(4):e0122931. PubMed ID: 25849793
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice.
Chen J; Reheman A; Gushiken FC; Nolasco L; Fu X; Moake JL; Ni H; López JA
J Clin Invest; 2011 Feb; 121(2):593-603. PubMed ID: 21266777
[TBL] [Abstract][Full Text] [Related]
19. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.
Nishio K; Anderson PJ; Zheng XL; Sadler JE
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10578-83. PubMed ID: 15249683
[TBL] [Abstract][Full Text] [Related]
20. Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.
Donadelli R; Orje JN; Capoferri C; Remuzzi G; Ruggeri ZM
Blood; 2006 Mar; 107(5):1943-50. PubMed ID: 16293606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
